Found: 26
Select item for more details and to access through your institution.
Black, Hispanic patients with cancer at greater risk for COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Persistent poverty rates linked to higher cancer mortality rates.
- Published in:
- 2021
- By:
- Publication type:
- journal article
FDA center issues new guidelines, approves drugs.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cancer organizations, institutions mobilize together during the COVID-19 pandemic: When confronted with myriad patient and provider challenges, the international cancer community launched multiple collaborations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 875, doi. 10.1002/cncr.33344
- By:
- Publication type:
- Article
Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low‐molecular‐weight heparin.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 938, doi. 10.1002/cncr.33337
- By:
- Publication type:
- Article
Mobile messenger–initiated reminders improve longitudinal adherence in a community‐based, opportunistic colorectal cancer screening program: A single‐blind, crossover randomized controlled study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 914, doi. 10.1002/cncr.33336
- By:
- Publication type:
- Article
Survival outcomes of patients with localized FOXO1 fusion‐positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 946, doi. 10.1002/cncr.33334
- By:
- Publication type:
- Article
Relationship between insurance status and outcomes for patients with breast cancer in Missouri.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 931, doi. 10.1002/cncr.33330
- By:
- Publication type:
- Article
Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 957, doi. 10.1002/cncr.33329
- By:
- Publication type:
- Article
Long-term outcomes of pexidartinib in tenosynovial giant cell tumors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Random urine drug testing among patients receiving opioid therapy for cancer pain.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 968, doi. 10.1002/cncr.33326
- By:
- Publication type:
- Article
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome–positive relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 905, doi. 10.1002/cncr.33321
- By:
- Publication type:
- Article
Health‐related quality‐of‐life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE‐240.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 865, doi. 10.1002/cncr.33317
- By:
- Publication type:
- Article
The challenge of drug approval in rare cancers.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 840, doi. 10.1002/cncr.33328
- By:
- Publication type:
- Article
Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk‐based testing of those older than 60 years.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 828, doi. 10.1002/cncr.33305
- By:
- Publication type:
- Article
Weighing the influence of race and obesity on outcomes in patients with early‐stage breast cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 834, doi. 10.1002/cncr.33290
- By:
- Publication type:
- Article
Obesity, comorbidities, and treatment selection in Black and White women with early breast cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 922, doi. 10.1002/cncr.33288
- By:
- Publication type:
- Article
Comment on low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 976, doi. 10.1002/cncr.33282
- By:
- Publication type:
- Article
Reply to Comment on low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 976, doi. 10.1002/cncr.33281
- By:
- Publication type:
- Article
Blood‐based biomarkers of human papillomavirus–associated cancers: A systematic review and meta‐analysis.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 850, doi. 10.1002/cncr.33221
- By:
- Publication type:
- Article
Reply to Colorectal cancer and COVID-19: Do we need to raise awareness and vigilance?
- Published in:
- 2021
- By:
- Publication type:
- Letter
Colorectal cancer and COVID-19: Do we need to raise awareness and vigilance?
- Published in:
- 2021
- By:
- Publication type:
- Letter
A randomized, open‐label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft‐tissue sarcoma.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 894, doi. 10.1002/cncr.33216
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 815, doi. 10.1002/cncr.32306
- Publication type:
- Article